Exicure Inc
Change company Symbol lookup
Select an option...
XCUR Exicure Inc
TUSK Mammoth Energy Services Inc
MRK Merck & Co Inc
WU Western Union Co
XFLS Xfuels Inc
WAFD Washington Federal Inc
CNIKF Canada Nickel Company Inc
VMW VMware Inc
FORM FormFactor Inc
GLNG Golar LNG Ltd
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Growth
Company profile

Exicure, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing therapeutics for neurology, immuno-oncology, inflammatory diseases and other genetic disorders based on its spherical nucleic acid (SNA) technology. The Company develops XCUR-FXN, which is a spherical nucleic acid (SNA) -based therapeutic candidate for the treatment of Friedreich’s ataxia (FA). XCUR-FXN through its SNA technology incorporates more than one active oligonucleotides in a single SNA molecule. The Company’s therapeutic candidate cavrotolimod (AST-008) is a toll-like receptor 9 (TLR9) agonist designed for immuno-oncology applications utilizing its SNA technology. AST-008 is in a Phase I b/II clinical trial in patients with advanced solid tumors. TLR9 agonists binds to and activate TLR9.

Closing Price
$0.1166
Day's Change
-0.0003 (-0.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.12
Day's Low
0.103
Volume
(Light)
Volume:
5,328,339

10-day average volume:
23,307,757
5,328,339
  • Prev Close
    0.1169
  • Today's Open
    0.113
  • Day's Range
    0.103-0.12
  • Avg Vol (10-day)
    23.3M
  • Last (time)
    4:00p ET 05/25/22
  • Last (size)
    112
  • 52-Wk Range
    0.095 - 1.98
    LowHigh
  • (08/02/21 - 05/12/22)
    22.74%
  • 124.0%
  • Market Cap
    14.3M
  • Shares Outstanding
    122.8M
  • -0.65
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.2
  • 19.26
  • (% of float 04/29/22)
    2.19

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.